- Q1 2024 CytomX Therapeutics Inc Earnings Call TranscriptMay 08, 2024$4.19 (+2.95%)Earnings
- Q4 2023 CytomX Therapeutics Inc Earnings Call TranscriptMar 11, 2024$2.51 (+0.40%)Earnings
- CytomX Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 CytomX Therapeutics Inc Earnings Call TranscriptNov 07, 2023$1.28 (+0.79%)Earnings
- CytomX Therapeutics Inc at HC Wainwright Immune Cell Engager Virtual Conference TranscriptAug 17, 2023
- Q2 2023 CytomX Therapeutics Inc Earnings Call TranscriptAug 08, 2023$1.69 (-0.59%)Earnings
- CytomX Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 CytomX Therapeutics Inc Earnings Call TranscriptMay 09, 2023$1.72 (+2.38%)Earnings
- CytomX Therapeutics Inc at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- Q4 2022 CytomX Therapeutics Inc Earnings Call TranscriptMar 27, 2023$1.79 (+5.29%)Earnings
- CytomX Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- CytomX Therapeutics Inc at B Riley Securities Oncology Conference (Virtual) TranscriptJan 19, 2023
- CytomX Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- CytomX Therapeutics Inc Pipeline Priorities for 2023 and Update for the CX-2029 Phase 2 Cohort Expansion Study - Corporate Call TranscriptJan 05, 2023
- Q3 2022 CytomX Therapeutics Inc Earnings Call TranscriptNov 08, 2022$1.23 (-1.60%)Earnings
- Q2 2022 CytomX Therapeutics Inc Earnings Call TranscriptAug 04, 2022$1.63 (+3.82%)Earnings
- CytomX Therapeutics Inc Business and Strategy Update Call TranscriptJul 13, 2022
- CytomX Therapeutics Inc Praluzatamab Ravtansine Phase 2 Study Results Call TranscriptJul 06, 2022
- Q1 2022 CytomX Therapeutics Inc Earnings Call TranscriptMay 05, 2022$1.61 (-5.85%)Earnings
- Q4 2021 CytomX Therapeutics Inc Earnings Call TranscriptMar 01, 2022$3.54 (-7.57%)Earnings
- CytomX Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- CytomX Therapeutics Inc To Discuss CX-2029 Preliminary Phase 2 Expansion Study Results Conference Call TranscriptDec 20, 2021
- Q3 2021 CytomX Therapeutics Inc Earnings Call TranscriptNov 04, 2021$5.98 (-1.97%)Earnings
- Q2 2021 CytomX Therapeutics Inc Earnings Call TranscriptAug 05, 2021$5.79 (+3.76%)Earnings
- Q1 2021 CytomX Therapeutics Inc Earnings Call TranscriptMay 06, 2021$8.15 (-4.45%)Earnings
- CytomX Therapeutics Inc Investor Event - Corporate Call TranscriptApr 07, 2021
- CytomX Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 CytomX Therapeutics Inc Earnings Call TranscriptFeb 24, 2021$8.04 (+0.37%)Earnings
- CytomX Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 CytomX Therapeutics Inc Earnings Call TranscriptNov 05, 2020$7.07Earnings
- Q2 2020 CytomX Therapeutics Inc Earnings Call TranscriptAug 06, 2020$7.55 (+1.34%)Earnings
- CytomX Therapeutics Inc Annual Shareholders Meeting TranscriptJun 17, 2020
- CytomX Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- CytomX Therapeutics, Inc. - Special Call TranscriptMay 29, 2020
- CytomX Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 CytomX Therapeutics Inc Earnings Call TranscriptMay 07, 2020$12.25 (+1.66%)Earnings
- CytomX Therapeutics, Inc. - Special Call TranscriptMar 30, 2020
- Q4 2019 CytomX Therapeutics Inc Earnings Call TranscriptFeb 27, 2020$7.13 (-1.86%)Earnings
- Q3 2019 CytomX Therapeutics Inc Earnings Call TranscriptNov 07, 2019$6.15 (+0.82%)Earnings
- CytomX Therapeutics Inc at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 CytomX Therapeutics Inc Earnings Call TranscriptAug 07, 2019$10.92 (+2.63%)Earnings
- CytomX Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- CytomX Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 16, 2019
- Q1 2019 CytomX Therapeutics Inc Earnings Call TranscriptMay 09, 2019$10.04 (-0.10%)Earnings
- CytomX Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Full Year 2018 CytomX Therapeutics Inc Earnings Call TranscriptFeb 27, 2019$12.73 (-3.05%)Earnings
- CytomX Therapeutics, Inc. - Special Call TranscriptFeb 26, 2019
Q1 2024 CytomX Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the CytomX Therapeutics First. Quarter 2024 financial results conference call. (Operator Instructions) please be advised that today's conference is being recorded I would now like to hand the conference over to your speaker today, Chris Ogden, CytomX's Senior Vice President, Finance and Accounting. Please go ahead.
Thank you.
Good afternoon, and thank you for joining us.
Before we begin, I would like to remind everyone that during this call, we will be making forward-looking statements Because forward-looking statements relate to the future that are subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our control. Important risks and uncertainties are set forth in our most recent public filings with the SEC at SEC.gov. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)